• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-消除降解法制备去岩藻糖硫酸软骨素及其片段的抗凝血活性

β-Eliminative depolymerization of the fucosylated chondroitin sulfate and anticoagulant activities of resulting fragments.

机构信息

State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China; University of Chinese Academy of Sciences, Beijing, China.

College of Pharmacy and Chemistry, Dali University, Dali, China.

出版信息

Carbohydr Polym. 2015;127:427-37. doi: 10.1016/j.carbpol.2015.04.002. Epub 2015 Apr 10.

DOI:10.1016/j.carbpol.2015.04.002
PMID:25965502
Abstract

Fucosylated chondroitin sulfate (FCS) from sea cucumber with complex structure has potent anticoagulant activity by inhibition of intrinsic tenase; however, it could activate factor XII and platelet. To obtain FCS' fragments with selective inhibition on intrinsic tenase, a method for β-eliminative depolymerization of FCS was developed by treating FCS benzyl esters with alkaline in anhydrous solution. Our results demonstrated that the glycosidic linkages of GalNAc-β1, 4-GlcA were selectively cleaved and distinctive Δ(4,5) unsaturated hexuronic acid was formed at non-reducing end of resulting fragments, while the main structures were essentially stable during depolymerization. By this method, five depolymerized fragments (dFCSs) with various molecular sizes were prepared and their anticoagulant activities and activation activities of factor XII and platelet were compared. Overall, dFCSs with Mw 3.2-8.8 kDa reserved potent anticoagulant activities by inhibition of intrinsic tenase, and activation activities of factor XII or platelet could be diminished or eliminated.

摘要

岩藻糖基硫酸软骨素(FCS)具有复杂的结构,它通过抑制内源性凝血酶而具有很强的抗凝活性;然而,它也可以激活因子 XII 和血小板。为了获得对内在凝血酶具有选择性抑制作用的 FCS 片段,通过用碱性在无水溶液中处理 FCS 苄酯,开发了一种 FCS 的β消除解聚方法。我们的结果表明,GalNAc-β1,4-GlcA 的糖苷键被选择性切割,并且在所得片段的非还原端形成独特的 Δ(4,5) 不饱和六糖醛酸,而主要结构在解聚过程中基本稳定。通过这种方法,制备了五种具有不同分子量的解聚片段(dFCS),并比较了它们的抗凝活性以及对因子 XII 和血小板的激活活性。总体而言,Mw 为 3.2-8.8 kDa 的 dFCS 通过抑制内源性凝血酶保留了很强的抗凝活性,并且可以减少或消除对因子 XII 或血小板的激活活性。

相似文献

1
β-Eliminative depolymerization of the fucosylated chondroitin sulfate and anticoagulant activities of resulting fragments.β-消除降解法制备去岩藻糖硫酸软骨素及其片段的抗凝血活性
Carbohydr Polym. 2015;127:427-37. doi: 10.1016/j.carbpol.2015.04.002. Epub 2015 Apr 10.
2
Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.岩藻糖基硫酸软骨素寡糖通过靶向内在凝血酶原复合物并低激活 FXII 发挥抗凝活性:硫酸化模式和分子大小的重要性。
Eur J Med Chem. 2017 Oct 20;139:191-200. doi: 10.1016/j.ejmech.2017.07.065. Epub 2017 Jul 28.
3
Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase.天然岩藻糖基化硫酸软骨素及其衍生物作为内源性X因子酶选择性抑制剂的抗凝和抗血栓形成评估
Eur J Med Chem. 2015 Mar 6;92:257-69. doi: 10.1016/j.ejmech.2014.12.054. Epub 2014 Dec 30.
4
Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.岩藻糖分支的硫酸化模式对于岩藻糖基化硫酸软骨素的抗凝和抗血栓形成活性很重要。
Biochim Biophys Acta. 2013 Apr;1830(4):3054-66. doi: 10.1016/j.bbagen.2013.01.001. Epub 2013 Jan 9.
5
Molecular size is important for the safety and selective inhibition of intrinsic factor Xase for fucosylated chondroitin sulfate.分子大小对于法糖基化硫酸软骨素固有因子 X 酶的安全性和选择性抑制很重要。
Carbohydr Polym. 2017 Dec 15;178:180-189. doi: 10.1016/j.carbpol.2017.09.034. Epub 2017 Sep 12.
6
Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.一种岩藻糖基化硫酸软骨素的丝氨酸蛋白酶抑制剂非依赖性抗凝活性。
Thromb Haemost. 2008 Sep;100(3):420-8.
7
Depolymerization of fucosylated chondroitin sulfate from sea cucumber, Pearsonothuria graeffei, via 60Co irradiation.通过 60Co 辐照从海参(糙海参)中降解岩藻糖基硫酸软骨素。
Carbohydr Polym. 2013 Apr 2;93(2):604-14. doi: 10.1016/j.carbpol.2012.12.044. Epub 2012 Dec 26.
8
Depolymerized glycosaminoglycan and its anticoagulant activities from sea cucumber Apostichopus japonicus.海参(Apostichopus japonicus)来源的解聚糖胺聚糖及其抗凝活性。
Int J Biol Macromol. 2015 Jan;72:699-705. doi: 10.1016/j.ijbiomac.2014.09.025. Epub 2014 Sep 23.
9
Highly purified fucosylated chondroitin sulfate oligomers with selective intrinsic factor Xase complex inhibition.高度纯化的岩藻糖基硫酸软骨素低聚糖,具有选择性固有因子 Xa 酶复合物抑制作用。
Carbohydr Polym. 2019 Oct 15;222:115025. doi: 10.1016/j.carbpol.2019.115025. Epub 2019 Jun 27.
10
Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.富含 2,4-二硫酸岩藻糖基单元的多糖对凝血、血栓形成和出血的影响。实际和概念上的意义。
Thromb Haemost. 2009 Nov;102(5):829-36. doi: 10.1160/TH08-11-0773.

引用本文的文献

1
Structural Characterization and Anticoagulant Potential of Fucosylated Glycosaminoglycan 5-12 Oligomers with Unusual Branches.具有异常分支的岩藻糖基化糖胺聚糖5-12寡聚物的结构表征及抗凝潜力
Mar Drugs. 2025 Feb 1;23(2):64. doi: 10.3390/md23020064.
2
Structural Analysis and Anticoagulant Activity of Fucosylated Glycosaminoglycan from Sea Cucumber .海参岩藻糖基化糖胺聚糖的结构分析及抗凝活性
Foods. 2024 Sep 12;13(18):2889. doi: 10.3390/foods13182889.
3
Purification and Structural Analyses of Sulfated Polysaccharides from Low-Value Sea Cucumber and Anticoagulant Activities of Its Oligosaccharides.
低值海参硫酸多糖的分离纯化与结构分析及其寡糖的抗凝活性。
Mar Drugs. 2024 Jun 8;22(6):265. doi: 10.3390/md22060265.
4
Chemical Synthesis of Fucosylated Chondroitin Sulfate Tetrasaccharide with Fucosyl Branch at the 6-OH of GalNAc Residue.糖基化硫酸软骨素四糖的 6-OH 位带有岩藻糖支链的化学合成
Mar Drugs. 2024 Apr 19;22(4):184. doi: 10.3390/md22040184.
5
Marine Biological Macromolecules and Chemically Modified Macromolecules; Potential Anticoagulants.海洋生物大分子和化学修饰的大分子;潜在的抗凝剂。
Mar Drugs. 2022 Oct 21;20(10):654. doi: 10.3390/md20100654.
6
The Phospholipid Molecular Species Profile of Tissues Modifies through Exposure to n-3 Polyunsaturated Fatty Acid-Deficient Diet.组织的磷脂分子种类谱通过暴露于 n-3 多不饱和脂肪酸缺乏饮食而改变。
Mar Drugs. 2022 Sep 15;20(9):578. doi: 10.3390/md20090578.
7
Critical Quality Control Methods for a Novel Anticoagulant Candidate LFG-Na by HPSEC-MALLS-RID and Bioactivity Assays.新型抗凝候选药物 LFG-Na 的高效凝胶渗透色谱-多角度激光散射-折射率检测和生物活性分析的关键质量控制方法。
Molecules. 2022 Jul 15;27(14):4522. doi: 10.3390/molecules27144522.
8
Semisynthetic Isomers of Fucosylated Chondroitin Sulfate Polysaccharides with Fucosyl Branches at a Non-Natural Site.非天然位点带有岩藻糖支链的岩藻糖基化硫酸软骨素多糖的半合成异构体。
Biomacromolecules. 2021 Dec 13;22(12):5151-5161. doi: 10.1021/acs.biomac.1c01112. Epub 2021 Nov 14.
9
The Toxicology of Native Fucosylated Glycosaminoglycans and the Safety of Their Depolymerized Products as Anticoagulants.天然岩藻糖基化糖胺聚糖的毒理学及解聚产物作为抗凝剂的安全性。
Mar Drugs. 2021 Aug 27;19(9):487. doi: 10.3390/md19090487.
10
Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from , a Novel Anticoagulant Candidate, in Rats by Bioanalytical Methods.用生物分析方法研究新型抗凝候选药物 去聚合糖胺聚糖的药代动力学和药效动力学在大鼠中的表现。
Mar Drugs. 2021 Apr 11;19(4):212. doi: 10.3390/md19040212.